A 265-Nanometer High-Power Deep-UV Light-Emitting Diode Rapidly Inactivates SARS-CoV-2 Aerosols
We developed a 265-nm high-power DUV-LED irradiation system and quantitatively demonstrated that the DUV-LED can inactivate SARS-CoV-2 in suspensions and aerosols within very short irradiation times. We also found that the inactivation effect was about nine times greater against aerosolized SARS-CoV...
Saved in:
| Published in | mSphere Vol. 7; no. 2; p. e0094121 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
American Society for Microbiology
27.04.2022
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | We developed a 265-nm high-power DUV-LED irradiation system and quantitatively demonstrated that the DUV-LED can inactivate SARS-CoV-2 in suspensions and aerosols within very short irradiation times. We also found that the inactivation effect was about nine times greater against aerosolized SARS-CoV-2 than against SARS-CoV-2 suspensions.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (COVID-19) is an acute respiratory infection transmitted by droplets, aerosols, and contact. Controlling the spread of COVID-19 and developing effective decontamination options are urgent issues for the international community. Here, we report the quantitative inactivation of SARS-CoV-2 in liquid and aerosolized samples by a state-of-the-art, high-power, AlGaN-based, single-chip compact deep-UV (DUV) light-emitting diode (LED) that produces a record continuous-wave output power of 500 mW at its peak emission wavelength of 265 nm. Using this DUV-LED, we observed a greater-than-5-log reduction in infectious SARS-CoV-2 in liquid samples within very short irradiation times (<0.4 s). When we quantified the efficacy of the 265-nm DUV-LED in inactivating SARS-CoV-2, we found that DUV-LED inactivation of aerosolized SARS-CoV-2 was approximately nine times greater than that of SARS-CoV-2 suspension. Our data demonstrate that this newly developed, compact, high-power 265-nm DUV-LED irradiation system with remarkably high inactivation efficiency for aerosolized SARS-CoV-2 could be an effective and practical tool for controlling SARS-CoV-2 spread.
IMPORTANCE
We developed a 265-nm high-power DUV-LED irradiation system and quantitatively demonstrated that the DUV-LED can inactivate SARS-CoV-2 in suspensions and aerosols within very short irradiation times. We also found that the inactivation effect was about nine times greater against aerosolized SARS-CoV-2 than against SARS-CoV-2 suspensions. The DUV-LED has several advantages over conventional LEDs and mercury lamps, including high power, compactness, and environmental friendliness; its rapid inactivation of aerosolized SARS-CoV-2 opens up new possibilities for the practical application of DUV-LEDs in high-efficiency air purification systems to control airborne transmission of SARS-CoV-2. |
|---|---|
| AbstractList | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (COVID-19) is an acute respiratory infection transmitted by droplets, aerosols, and contact. Controlling the spread of COVID-19 and developing effective decontamination options are urgent issues for the international community. Here, we report the quantitative inactivation of SARS-CoV-2 in liquid and aerosolized samples by a state-of-the-art, high-power, AlGaN-based, single-chip compact deep-UV (DUV) light-emitting diode (LED) that produces a record continuous-wave output power of 500 mW at its peak emission wavelength of 265 nm. Using this DUV-LED, we observed a greater-than-5-log reduction in infectious SARS-CoV-2 in liquid samples within very short irradiation times (<0.4 s). When we quantified the efficacy of the 265-nm DUV-LED in inactivating SARS-CoV-2, we found that DUV-LED inactivation of aerosolized SARS-CoV-2 was approximately nine times greater than that of SARS-CoV-2 suspension. Our data demonstrate that this newly developed, compact, high-power 265-nm DUV-LED irradiation system with remarkably high inactivation efficiency for aerosolized SARS-CoV-2 could be an effective and practical tool for controlling SARS-CoV-2 spread.
IMPORTANCE
We developed a 265-nm high-power DUV-LED irradiation system and quantitatively demonstrated that the DUV-LED can inactivate SARS-CoV-2 in suspensions and aerosols within very short irradiation times. We also found that the inactivation effect was about nine times greater against aerosolized SARS-CoV-2 than against SARS-CoV-2 suspensions. The DUV-LED has several advantages over conventional LEDs and mercury lamps, including high power, compactness, and environmental friendliness; its rapid inactivation of aerosolized SARS-CoV-2 opens up new possibilities for the practical application of DUV-LEDs in high-efficiency air purification systems to control airborne transmission of SARS-CoV-2. ABSTRACT Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (COVID-19) is an acute respiratory infection transmitted by droplets, aerosols, and contact. Controlling the spread of COVID-19 and developing effective decontamination options are urgent issues for the international community. Here, we report the quantitative inactivation of SARS-CoV-2 in liquid and aerosolized samples by a state-of-the-art, high-power, AlGaN-based, single-chip compact deep-UV (DUV) light-emitting diode (LED) that produces a record continuous-wave output power of 500 mW at its peak emission wavelength of 265 nm. Using this DUV-LED, we observed a greater-than-5-log reduction in infectious SARS-CoV-2 in liquid samples within very short irradiation times (<0.4 s). When we quantified the efficacy of the 265-nm DUV-LED in inactivating SARS-CoV-2, we found that DUV-LED inactivation of aerosolized SARS-CoV-2 was approximately nine times greater than that of SARS-CoV-2 suspension. Our data demonstrate that this newly developed, compact, high-power 265-nm DUV-LED irradiation system with remarkably high inactivation efficiency for aerosolized SARS-CoV-2 could be an effective and practical tool for controlling SARS-CoV-2 spread. IMPORTANCE We developed a 265-nm high-power DUV-LED irradiation system and quantitatively demonstrated that the DUV-LED can inactivate SARS-CoV-2 in suspensions and aerosols within very short irradiation times. We also found that the inactivation effect was about nine times greater against aerosolized SARS-CoV-2 than against SARS-CoV-2 suspensions. The DUV-LED has several advantages over conventional LEDs and mercury lamps, including high power, compactness, and environmental friendliness; its rapid inactivation of aerosolized SARS-CoV-2 opens up new possibilities for the practical application of DUV-LEDs in high-efficiency air purification systems to control airborne transmission of SARS-CoV-2. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (COVID-19) is an acute respiratory infection transmitted by droplets, aerosols, and contact. Controlling the spread of COVID-19 and developing effective decontamination options are urgent issues for the international community. Here, we report the quantitative inactivation of SARS-CoV-2 in liquid and aerosolized samples by a state-of-the-art, high-power, AlGaN-based, single-chip compact deep-UV (DUV) light-emitting diode (LED) that produces a record continuous-wave output power of 500 mW at its peak emission wavelength of 265 nm. Using this DUV-LED, we observed a greater-than-5-log reduction in infectious SARS-CoV-2 in liquid samples within very short irradiation times (<0.4 s). When we quantified the efficacy of the 265-nm DUV-LED in inactivating SARS-CoV-2, we found that DUV-LED inactivation of aerosolized SARS-CoV-2 was approximately nine times greater than that of SARS-CoV-2 suspension. Our data demonstrate that this newly developed, compact, high-power 265-nm DUV-LED irradiation system with remarkably high inactivation efficiency for aerosolized SARS-CoV-2 could be an effective and practical tool for controlling SARS-CoV-2 spread. IMPORTANCE We developed a 265-nm high-power DUV-LED irradiation system and quantitatively demonstrated that the DUV-LED can inactivate SARS-CoV-2 in suspensions and aerosols within very short irradiation times. We also found that the inactivation effect was about nine times greater against aerosolized SARS-CoV-2 than against SARS-CoV-2 suspensions. The DUV-LED has several advantages over conventional LEDs and mercury lamps, including high power, compactness, and environmental friendliness; its rapid inactivation of aerosolized SARS-CoV-2 opens up new possibilities for the practical application of DUV-LEDs in high-efficiency air purification systems to control airborne transmission of SARS-CoV-2.Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (COVID-19) is an acute respiratory infection transmitted by droplets, aerosols, and contact. Controlling the spread of COVID-19 and developing effective decontamination options are urgent issues for the international community. Here, we report the quantitative inactivation of SARS-CoV-2 in liquid and aerosolized samples by a state-of-the-art, high-power, AlGaN-based, single-chip compact deep-UV (DUV) light-emitting diode (LED) that produces a record continuous-wave output power of 500 mW at its peak emission wavelength of 265 nm. Using this DUV-LED, we observed a greater-than-5-log reduction in infectious SARS-CoV-2 in liquid samples within very short irradiation times (<0.4 s). When we quantified the efficacy of the 265-nm DUV-LED in inactivating SARS-CoV-2, we found that DUV-LED inactivation of aerosolized SARS-CoV-2 was approximately nine times greater than that of SARS-CoV-2 suspension. Our data demonstrate that this newly developed, compact, high-power 265-nm DUV-LED irradiation system with remarkably high inactivation efficiency for aerosolized SARS-CoV-2 could be an effective and practical tool for controlling SARS-CoV-2 spread. IMPORTANCE We developed a 265-nm high-power DUV-LED irradiation system and quantitatively demonstrated that the DUV-LED can inactivate SARS-CoV-2 in suspensions and aerosols within very short irradiation times. We also found that the inactivation effect was about nine times greater against aerosolized SARS-CoV-2 than against SARS-CoV-2 suspensions. The DUV-LED has several advantages over conventional LEDs and mercury lamps, including high power, compactness, and environmental friendliness; its rapid inactivation of aerosolized SARS-CoV-2 opens up new possibilities for the practical application of DUV-LEDs in high-efficiency air purification systems to control airborne transmission of SARS-CoV-2. ABSTRACTSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (COVID-19) is an acute respiratory infection transmitted by droplets, aerosols, and contact. Controlling the spread of COVID-19 and developing effective decontamination options are urgent issues for the international community. Here, we report the quantitative inactivation of SARS-CoV-2 in liquid and aerosolized samples by a state-of-the-art, high-power, AlGaN-based, single-chip compact deep-UV (DUV) light-emitting diode (LED) that produces a record continuous-wave output power of 500 mW at its peak emission wavelength of 265 nm. Using this DUV-LED, we observed a greater-than-5-log reduction in infectious SARS-CoV-2 in liquid samples within very short irradiation times (<0.4 s). When we quantified the efficacy of the 265-nm DUV-LED in inactivating SARS-CoV-2, we found that DUV-LED inactivation of aerosolized SARS-CoV-2 was approximately nine times greater than that of SARS-CoV-2 suspension. Our data demonstrate that this newly developed, compact, high-power 265-nm DUV-LED irradiation system with remarkably high inactivation efficiency for aerosolized SARS-CoV-2 could be an effective and practical tool for controlling SARS-CoV-2 spread.IMPORTANCE We developed a 265-nm high-power DUV-LED irradiation system and quantitatively demonstrated that the DUV-LED can inactivate SARS-CoV-2 in suspensions and aerosols within very short irradiation times. We also found that the inactivation effect was about nine times greater against aerosolized SARS-CoV-2 than against SARS-CoV-2 suspensions. The DUV-LED has several advantages over conventional LEDs and mercury lamps, including high power, compactness, and environmental friendliness; its rapid inactivation of aerosolized SARS-CoV-2 opens up new possibilities for the practical application of DUV-LEDs in high-efficiency air purification systems to control airborne transmission of SARS-CoV-2. We developed a 265-nm high-power DUV-LED irradiation system and quantitatively demonstrated that the DUV-LED can inactivate SARS-CoV-2 in suspensions and aerosols within very short irradiation times. We also found that the inactivation effect was about nine times greater against aerosolized SARS-CoV-2 than against SARS-CoV-2 suspensions. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (COVID-19) is an acute respiratory infection transmitted by droplets, aerosols, and contact. Controlling the spread of COVID-19 and developing effective decontamination options are urgent issues for the international community. Here, we report the quantitative inactivation of SARS-CoV-2 in liquid and aerosolized samples by a state-of-the-art, high-power, AlGaN-based, single-chip compact deep-UV (DUV) light-emitting diode (LED) that produces a record continuous-wave output power of 500 mW at its peak emission wavelength of 265 nm. Using this DUV-LED, we observed a greater-than-5-log reduction in infectious SARS-CoV-2 in liquid samples within very short irradiation times (<0.4 s). When we quantified the efficacy of the 265-nm DUV-LED in inactivating SARS-CoV-2, we found that DUV-LED inactivation of aerosolized SARS-CoV-2 was approximately nine times greater than that of SARS-CoV-2 suspension. Our data demonstrate that this newly developed, compact, high-power 265-nm DUV-LED irradiation system with remarkably high inactivation efficiency for aerosolized SARS-CoV-2 could be an effective and practical tool for controlling SARS-CoV-2 spread. IMPORTANCE We developed a 265-nm high-power DUV-LED irradiation system and quantitatively demonstrated that the DUV-LED can inactivate SARS-CoV-2 in suspensions and aerosols within very short irradiation times. We also found that the inactivation effect was about nine times greater against aerosolized SARS-CoV-2 than against SARS-CoV-2 suspensions. The DUV-LED has several advantages over conventional LEDs and mercury lamps, including high power, compactness, and environmental friendliness; its rapid inactivation of aerosolized SARS-CoV-2 opens up new possibilities for the practical application of DUV-LEDs in high-efficiency air purification systems to control airborne transmission of SARS-CoV-2. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (COVID-19) is an acute respiratory infection transmitted by droplets, aerosols, and contact. Controlling the spread of COVID-19 and developing effective decontamination options are urgent issues for the international community. Here, we report the quantitative inactivation of SARS-CoV-2 in liquid and aerosolized samples by a state-of-the-art, high-power, AlGaN-based, single-chip compact deep-UV (DUV) light-emitting diode (LED) that produces a record continuous-wave output power of 500 mW at its peak emission wavelength of 265 nm. Using this DUV-LED, we observed a greater-than-5-log reduction in infectious SARS-CoV-2 in liquid samples within very short irradiation times (<0.4 s). When we quantified the efficacy of the 265-nm DUV-LED in inactivating SARS-CoV-2, we found that DUV-LED inactivation of aerosolized SARS-CoV-2 was approximately nine times greater than that of SARS-CoV-2 suspension. Our data demonstrate that this newly developed, compact, high-power 265-nm DUV-LED irradiation system with remarkably high inactivation efficiency for aerosolized SARS-CoV-2 could be an effective and practical tool for controlling SARS-CoV-2 spread. We developed a 265-nm high-power DUV-LED irradiation system and quantitatively demonstrated that the DUV-LED can inactivate SARS-CoV-2 in suspensions and aerosols within very short irradiation times. We also found that the inactivation effect was about nine times greater against aerosolized SARS-CoV-2 than against SARS-CoV-2 suspensions. The DUV-LED has several advantages over conventional LEDs and mercury lamps, including high power, compactness, and environmental friendliness; its rapid inactivation of aerosolized SARS-CoV-2 opens up new possibilities for the practical application of DUV-LEDs in high-efficiency air purification systems to control airborne transmission of SARS-CoV-2. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (COVID-19) is an acute respiratory infection transmitted by droplets, aerosols, and contact. Controlling the spread of COVID-19 and developing effective decontamination options are urgent issues for the international community. Here, we report the quantitative inactivation of SARS-CoV-2 in liquid and aerosolized samples by a state-of-the-art, high-power, AlGaN-based, single-chip compact deep-UV (DUV) light-emitting diode (LED) that produces a record continuous-wave output power of 500 mW at its peak emission wavelength of 265 nm. Using this DUV-LED, we observed a greater-than-5-log reduction in infectious SARS-CoV-2 in liquid samples within very short irradiation times (<0.4 s). When we quantified the efficacy of the 265-nm DUV-LED in inactivating SARS-CoV-2, we found that DUV-LED inactivation of aerosolized SARS-CoV-2 was approximately nine times greater than that of SARS-CoV-2 suspension. Our data demonstrate that this newly developed, compact, high-power 265-nm DUV-LED irradiation system with remarkably high inactivation efficiency for aerosolized SARS-CoV-2 could be an effective and practical tool for controlling SARS-CoV-2 spread. IMPORTANCE We developed a 265-nm high-power DUV-LED irradiation system and quantitatively demonstrated that the DUV-LED can inactivate SARS-CoV-2 in suspensions and aerosols within very short irradiation times. We also found that the inactivation effect was about nine times greater against aerosolized SARS-CoV-2 than against SARS-CoV-2 suspensions. The DUV-LED has several advantages over conventional LEDs and mercury lamps, including high power, compactness, and environmental friendliness; its rapid inactivation of aerosolized SARS-CoV-2 opens up new possibilities for the practical application of DUV-LEDs in high-efficiency air purification systems to control airborne transmission of SARS-CoV-2. |
| Author | Inoue, Shin-ichiro Ueki, Hiroshi Yamayoshi, Seiya Kawaoka, Yoshihiro Ito, Mutsumi Furusawa, Yuri |
| Author_xml | – sequence: 1 givenname: Hiroshi surname: Ueki fullname: Ueki, Hiroshi organization: Department of Virology, Institute of Medical Science, University of Tokyo, Tokyo, Japan, Center for Global Viral Diseases, National Center for Global Health and Medicine, Tokyo, Japan – sequence: 2 givenname: Mutsumi surname: Ito fullname: Ito, Mutsumi organization: Department of Virology, Institute of Medical Science, University of Tokyo, Tokyo, Japan – sequence: 3 givenname: Yuri surname: Furusawa fullname: Furusawa, Yuri organization: Department of Virology, Institute of Medical Science, University of Tokyo, Tokyo, Japan, Laboratory of Ultrastructural Virology, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan – sequence: 4 givenname: Seiya orcidid: 0000-0001-7768-5157 surname: Yamayoshi fullname: Yamayoshi, Seiya organization: Department of Virology, Institute of Medical Science, University of Tokyo, Tokyo, Japan, Center for Global Viral Diseases, National Center for Global Health and Medicine, Tokyo, Japan – sequence: 5 givenname: Shin-ichiro surname: Inoue fullname: Inoue, Shin-ichiro organization: Advanced ICT Research Institute, National Institute of Information and Communications Technology (NICT), Kobe, Japan – sequence: 6 givenname: Yoshihiro orcidid: 0000-0001-5061-8296 surname: Kawaoka fullname: Kawaoka, Yoshihiro organization: Department of Virology, Institute of Medical Science, University of Tokyo, Tokyo, Japan, Center for Global Viral Diseases, National Center for Global Health and Medicine, Tokyo, Japan, Department of Special Pathogens, International Research Center for Infectious Diseases, Institute of Medical Science, University of Tokyo, Tokyo, Japan, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35475734$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9ks1v0zAUwCM0xMbYnROKxIWLh79TX5CqbrBKFaBt7GrZyUvrKomD7Q7tv8ddO9gmwcnW8-_95PfxujgY_ABF8ZbgU0Lo5GMfxxUEOMVYcYIoeVEcUVYpJDCnB4_uh8VJjGuMMZFUykq-Kg6Z4JWoGD8q9LSkUqCvZvA9JAjlhVuu0Hf_K1_PAEb046Zc5FBC571LyQ3L8sz5BspLM7qmuyvng6mTuzUJYnk1vbxCM3-DaDmF4KPv4pviZWu6CCf787i4_nx-PbtAi29f5rPpAhmheEKqMlQy4IQxZkRjBc81KUKtslIomAgLNcOM1ZbS1tjKNEoq1VgKFGpi2XEx32kbb9Z6DK434U574_R9wIelNiG5ugPNZVuBpErgquWUGWsMbxijrJ1YguXW9WnnGje2h6aGIQXTPZE-fRncSi_9rVaY8_ytLPiwFwT_cwMx6d7FGrrODOA3UeeGS4oxFSKj75-ha78JQ-7UlqoUlnxCM4V2lIk9_UsQrLeLoPeLoO8XQVOS-XePK_jz9YexZ0DugDpPKQZode2SSc5vC3Ld_8z4WeKD-58pvwFqJNHp |
| CitedBy_id | crossref_primary_10_1088_1361_6463_ad056a crossref_primary_10_1109_JPHOT_2023_3276176 crossref_primary_10_1038_s41598_023_35247_9 crossref_primary_10_1088_1361_6463_ad039c crossref_primary_10_1016_j_envint_2022_107580 crossref_primary_10_1016_j_envint_2023_108022 crossref_primary_10_1021_acs_est_2c02822 crossref_primary_10_3390_ijerph192013706 crossref_primary_10_1016_j_jes_2024_09_026 crossref_primary_10_1002_jmv_27959 crossref_primary_10_1038_s41598_023_36610_6 crossref_primary_10_1016_j_jphotobiol_2024_112949 crossref_primary_10_1038_s41598_024_63472_3 crossref_primary_10_1128_spectrum_03424_22 |
| Cites_doi | 10.1038/s41598-021-93231-7 10.1093/infdis/jiaa274 10.1016/j.ajic.2020.07.031 10.1371/journal.pone.0103560 10.3390/covid1030050 10.1038/s41566-019-0359-9 10.1016/j.ijid.2020.09.025 10.1016/j.virol.2010.08.015 10.1063/1.4978855 10.1016/j.it.2020.10.004 10.1038/s41598-020-60459-8 10.1128/mSphere.00637-20 10.1073/pnas.2002589117 10.1056/NEJMc2013400 10.1038/nphoton.2007.293 10.3390/microorganisms8071014 10.1080/22221751.2020.1796529 10.1088/0268-1242/26/1/014036 10.1016/j.ajic.2020.08.022 10.1063/1.4915255 10.1007/s11356-009-0103-y 10.1038/s41598-020-67211-2 10.1016/j.watres.2005.10.030 |
| ContentType | Journal Article |
| Copyright | Copyright © 2022 Ueki et al. Copyright © 2022 Ueki et al. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Copyright © 2022 Ueki et al. 2022 Ueki et al. |
| Copyright_xml | – notice: Copyright © 2022 Ueki et al. – notice: Copyright © 2022 Ueki et al. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Copyright © 2022 Ueki et al. 2022 Ueki et al. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU COVID DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M7P PHGZM PHGZT PIMPY PKEHL PQEST PQGLB PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.1128/msphere.00941-21 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Coronavirus Research Database ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Biological Science Database ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Central (New) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Coronavirus Research Database ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database CrossRef MEDLINE |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 2379-5042 |
| Editor | Bouvier, Nicole M |
| Editor_xml | – sequence: 1 givenname: Nicole M surname: Bouvier fullname: Bouvier, Nicole M |
| ExternalDocumentID | oai_doaj_org_article_46f7e629507f423abaa4d3323f8b106b PMC9044969 00941-21 35475734 10_1128_msphere_00941_21 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: Japan Agency for Medical Research and Development (AMED) grantid: JP21wm0125002 funderid: https://doi.org/10.13039/100009619 – fundername: HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) grantid: HHSN272201400008C funderid: https://doi.org/10.13039/100000060 – fundername: Japan Agency for Medical Research and Development (AMED) grantid: 19fk0108113 funderid: https://doi.org/10.13039/100009619 – fundername: The Ministry of Health, Labour and Welfare of Japan grantid: 19HA1003 – fundername: MEXT | Japan Society for the Promotion of Science (JSPS) grantid: 20H00348 funderid: https://doi.org/10.13039/501100001691 – fundername: ; grantid: HHSN272201400008C – fundername: ; grantid: JP21wm0125002 – fundername: ; grantid: 20H00348 – fundername: ; grantid: 19fk0108113 – fundername: ; grantid: 19HA1003 |
| GroupedDBID | 0R~ 53G 5VS 7X7 8FE 8FH 8FI 8FJ AAFWJ AAGFI AAUOK AAYXX ABUWG ADBBV AFKRA AFPKN ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI CCPQU CITATION DIK EBS FRP FYUFA GROUPED_DOAJ H13 HCIFZ HMCUK HYE KQ8 LK8 M48 M7P M~E O9- OK1 PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC R9- RHI RPM RSF UKHRP CGR CUY CVF ECM EIF NPM PQGLB 0R 3V. ADACO BBAFP BXI PQEST PQUKI PRINS RHF 7XB 8FK AZQEC COVID DWQXO GNUQQ K9. PKEHL 7X8 5PM PUEGO |
| ID | FETCH-LOGICAL-a594t-97a263e41333a5db54941912b9b659e85bec3033cb22fab7ad9699db2e2ec1b3 |
| IEDL.DBID | M48 |
| ISSN | 2379-5042 |
| IngestDate | Wed Aug 27 01:21:52 EDT 2025 Thu Aug 21 14:11:21 EDT 2025 Fri Jul 11 10:36:55 EDT 2025 Fri Jul 25 11:55:55 EDT 2025 Thu Apr 28 03:17:36 EDT 2022 Mon Jul 21 05:59:34 EDT 2025 Tue Jul 01 02:17:03 EDT 2025 Thu Apr 24 23:05:57 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | COVID-19 SARS-CoV-2 LED aerosols deep UV |
| Language | English |
| License | This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license. https://creativecommons.org/licenses/by/4.0 This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-a594t-97a263e41333a5db54941912b9b659e85bec3033cb22fab7ad9699db2e2ec1b3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 The authors declare a conflict of interest. Yoshihiro Kawaoka has ongoing unrelated collaborations and/or sponsored research agreements with Daiichi Sankyo Pharmaceutical, Toyama Chemical, Tauns Laboratories, Inc., Shionogi & Co. Ltd., Otsuka Pharmaceutical, and KM Biologics and has received royalties from MedImmune and Integrated Biotherapeutics. |
| ORCID | 0000-0001-7768-5157 0000-0001-5061-8296 |
| OpenAccessLink | https://journals.asm.org/doi/10.1128/msphere.00941-21 |
| PMID | 35475734 |
| PQID | 2657906482 |
| PQPubID | 2045592 |
| PageCount | 7 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_46f7e629507f423abaa4d3323f8b106b pubmedcentral_primary_oai_pubmedcentral_nih_gov_9044969 proquest_miscellaneous_2656200255 proquest_journals_2657906482 asm2_journals_10_1128_msphere_00941_21 pubmed_primary_35475734 crossref_citationtrail_10_1128_msphere_00941_21 crossref_primary_10_1128_msphere_00941_21 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2022-04-27 |
| PublicationDateYYYYMMDD | 2022-04-27 |
| PublicationDate_xml | – month: 04 year: 2022 text: 2022-04-27 day: 27 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: 1752 N St., N.W., Washington, DC – name: Washington |
| PublicationTitle | mSphere |
| PublicationTitleAbbrev | mSphere |
| PublicationTitleAlternate | mSphere |
| PublicationYear | 2022 |
| Publisher | American Society for Microbiology |
| Publisher_xml | – name: American Society for Microbiology |
| References | e_1_3_2_9_2 e_1_3_2_15_2 e_1_3_2_8_2 e_1_3_2_16_2 e_1_3_2_7_2 e_1_3_2_17_2 e_1_3_2_6_2 e_1_3_2_18_2 e_1_3_2_19_2 Žukauskas A (e_1_3_2_10_2) 2002 e_1_3_2_20_2 e_1_3_2_21_2 e_1_3_2_5_2 e_1_3_2_11_2 e_1_3_2_22_2 e_1_3_2_4_2 e_1_3_2_12_2 e_1_3_2_23_2 e_1_3_2_3_2 e_1_3_2_13_2 e_1_3_2_24_2 e_1_3_2_2_2 e_1_3_2_14_2 e_1_3_2_25_2 Inoue, S-I, Naoki, T, Kinoshita, T, Obata, T, Yanagi, H (B16) 2015; 106 Vilhunen, S, Särkkä, H, Sillanpää, M (B8) 2009; 16 Lednicky, JA, Lauzard, M, Fan, ZH, Jutla, A, Tilly, TB, Gangwar, M, Usmani, M, Shankar, SN, Mohamed, K, Eiguren-Fernandez, A, Stephenson, CJ, Alam, MM, Elbadry, MA, Loeb, JC, Subramaniam, K, Waltzek, TB, Cherabuddi, K, Morris, JG, Wu, C-Y (B14) 2020; 100 Kneissl, M, Seong, T-Y, Han, J, Amano, H (B12) 2019; 13 Porterfield, JZ, Zlotnick, A (B15) 2010; 407 Žukauskas, A, Shur, MS, Gaska, R (B9) 2002 Hijnen, WA, Beerendonk, EF, Medema, GJ (B18) 2006; 40 Ratnesar-Shumate, S, Williams, G, Green, B, Krause, M, Holland, B, Wood, S, Bohannon, J, Boydston, J, Freeburger, D, Hooper, I, Beck, K, Yeager, J, Altamura, LA, Biryukov, J, Yolitz, J, Schuit, M, Wahl, V, Hevey, M, Dabisch, P (B5) 2020; 222 Inoue, S-I, Tamari, N, Taniguchi, M (B17) 2017; 110 Lo, C-W, Matsuura, R, Iimura, K, Wada, S, Shinjo, A, Benno, Y, Nakagawa, M, Takei, M, Aida, Y (B20) 2021; 11 Hatagishi, E, Okamoto, M, Ohmiya, S, Yano, H, Hori, T, Saito, W, Miki, H, Suzuki, Y, Saito, R, Yamamoto, T, Shoji, M, Morisaki, Y, Sakata, S, Nishimura, H (B23) 2014; 9 Kneissl, M, Kolbe, T, Chua, C, Kueller, V, Lobo, N, Stellmach, J, Knauer, A, Rodriguez, H, Einfeldt, S, Yang, Z, Johnson, NM, Weyers, M (B2) 2011; 26 Harrison, AG, Lin, T, Wang, P (B1) 2020; 41 Heilingloh, CS, Aufderhorst, UW, Schipper, L, Dittmer, U, Witzke, O, Yang, D, Zheng, X, Sutter, K, Trilling, M, Alt, M, Steinmann, E, Krawczyk, A (B4) 2020; 48 Bowen, RA, Gilgunn, P, Hartwig, AE, Mullen, J (B7) 2021; 1 Cheng, Y, Chen, H, Sánchez Basurto, LA, Protasenko, VV, Bharadwaj, S, Islam, M, Moraru, CI (B10) 2020; 10 Kojima, M, Mawatari, K, Emoto, T, Nishisaka-Nonaka, R, Bui, TKN, Shimohata, T, Uebanso, T, Akutagawa, M, Kinouchi, Y, Wada, T, Okamoto, M, Ito, H, Tojo, K, Daidoji, T, Nakaya, T, Takahashi, A (B3) 2020; 8 Kitagawa, H, Nomura, T, Nazmul, T, Omori, K, Shigemoto, N, Sakaguchi, T, Ohge, H (B6) 2021; 49 Buonanno, M, Welch, D, Shuryak, I, Brenner, DJ (B19) 2020; 10 Matsuyama, S, Nao, N, Shirato, K, Kawase, M, Saito, S, Takayama, I, Nagata, N, Sekizuka, T, Katoh, H, Kato, F, Sakata, M, Tahara, M, Kutsuna, S, Ohmagari, N, Kuroda, M, Suzuki, T, Kageyama, T, Takeda, M (B22) 2020; 117 Ueki, H, Furusawa, Y, Iwatsuki-Horimoto, K, Imai, M, Kabata, H, Nishimura, H, Kawaoka, Y (B24) 2020; 5 Inagaki, H, Saito, A, Sugiyama, H, Okabayashi, T, Fujimoto, S (B13) 2020; 9 Khan, A, Balakrishnan, K, Katona, T (B11) 2008; 2 Halfmann, PJ, Hatta, M, Chiba, S, Maemura, T, Fan, S, Takeda, M, Kinoshita, N, Hattori, S-I, Sakai-Tagawa, Y, Iwatsuki-Horimoto, K, Imai, M, Kawaoka, Y (B21) 2020; 383 |
| References_xml | – ident: e_1_3_2_21_2 doi: 10.1038/s41598-021-93231-7 – ident: e_1_3_2_6_2 doi: 10.1093/infdis/jiaa274 – ident: e_1_3_2_5_2 doi: 10.1016/j.ajic.2020.07.031 – ident: e_1_3_2_24_2 doi: 10.1371/journal.pone.0103560 – ident: e_1_3_2_8_2 doi: 10.3390/covid1030050 – ident: e_1_3_2_13_2 doi: 10.1038/s41566-019-0359-9 – ident: e_1_3_2_15_2 doi: 10.1016/j.ijid.2020.09.025 – ident: e_1_3_2_16_2 doi: 10.1016/j.virol.2010.08.015 – ident: e_1_3_2_18_2 doi: 10.1063/1.4978855 – ident: e_1_3_2_2_2 doi: 10.1016/j.it.2020.10.004 – ident: e_1_3_2_11_2 doi: 10.1038/s41598-020-60459-8 – ident: e_1_3_2_25_2 doi: 10.1128/mSphere.00637-20 – ident: e_1_3_2_23_2 doi: 10.1073/pnas.2002589117 – ident: e_1_3_2_22_2 doi: 10.1056/NEJMc2013400 – ident: e_1_3_2_12_2 doi: 10.1038/nphoton.2007.293 – volume-title: Introduction to solid-state lighting year: 2002 ident: e_1_3_2_10_2 – ident: e_1_3_2_4_2 doi: 10.3390/microorganisms8071014 – ident: e_1_3_2_14_2 doi: 10.1080/22221751.2020.1796529 – ident: e_1_3_2_3_2 doi: 10.1088/0268-1242/26/1/014036 – ident: e_1_3_2_7_2 doi: 10.1016/j.ajic.2020.08.022 – ident: e_1_3_2_17_2 doi: 10.1063/1.4915255 – ident: e_1_3_2_9_2 doi: 10.1007/s11356-009-0103-y – ident: e_1_3_2_20_2 doi: 10.1038/s41598-020-67211-2 – ident: e_1_3_2_19_2 doi: 10.1016/j.watres.2005.10.030 – volume: 10 start-page: 3411 year: 2020 ident: B10 article-title: Inactivation of Listeria and E. coli by deep-UV LED: effect of substrate conditions on inactivation kinetics publication-title: Sci Rep doi: 10.1038/s41598-020-60459-8 – volume: 1 start-page: 602 year: 2021 end-page: 607 ident: B7 article-title: Prevention of airborne transmission of SARS-CoV-2 by UV-C illumination of airflow publication-title: COVID doi: 10.3390/covid1030050 – volume: 41 start-page: 1100 year: 2020 end-page: 1115 ident: B1 article-title: Mechanisms of SARS-CoV-2 transmission and pathogenesis publication-title: Trends Immunol doi: 10.1016/j.it.2020.10.004 – volume: 117 start-page: 7001 year: 2020 end-page: 7003 ident: B22 article-title: Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.2002589117 – volume: 222 start-page: 214 year: 2020 end-page: 222 ident: B5 article-title: Simulated sunlight rapidly inactivates SARS-CoV-2 on surfaces publication-title: J Infect Dis doi: 10.1093/infdis/jiaa274 – year: 2002 ident: B9 publication-title: Introduction to solid-state lighting ;Wiley ;Hoboken, NJ – volume: 48 start-page: 1273 year: 2020 end-page: 1275 ident: B4 article-title: Susceptibility of SARS-CoV-2 to UV irradiation publication-title: Am J Infect Control doi: 10.1016/j.ajic.2020.07.031 – volume: 26 year: 2011 ident: B2 article-title: Advances in group III-nitride-based deep UV light-emitting diode technology publication-title: Semicond Sci Technol doi: 10.1088/0268-1242/26/1/014036 – volume: 49 start-page: 299 year: 2021 end-page: 301 ident: B6 article-title: Effectiveness of 222-nm ultraviolet light on disinfecting SARS-CoV-2 surface contamination publication-title: Am J Infect Control doi: 10.1016/j.ajic.2020.08.022 – volume: 10 start-page: 10285 year: 2020 ident: B19 article-title: Far-UVC light (222 nm) efficiently and safely inactivates airborne human coronaviruses publication-title: Sci Rep doi: 10.1038/s41598-020-67211-2 – volume: 2 start-page: 77 year: 2008 end-page: 84 ident: B11 article-title: Ultraviolet light-emitting diodes based on group three nitrides publication-title: Nat Photonics doi: 10.1038/nphoton.2007.293 – volume: 40 start-page: 3 year: 2006 end-page: 22 ident: B18 article-title: Inactivation credit of UV radiation for viruses, bacteria and protozoan (oo)cysts in water: a review publication-title: Water Res doi: 10.1016/j.watres.2005.10.030 – volume: 110 start-page: 141106 year: 2017 ident: B17 article-title: 150 mW deep-ultraviolet light-emitting diodes with large-area AlN nanophotonic light-extraction structure emitting at 265 nm publication-title: Appl Phys Lett doi: 10.1063/1.4978855 – volume: 9 start-page: 1744 year: 2020 end-page: 1747 ident: B13 article-title: Rapid inactivation of SARS-CoV-2 with deep-UV LED irradiation publication-title: Emerg Microbes Infect doi: 10.1080/22221751.2020.1796529 – volume: 11 start-page: 13804 year: 2021 ident: B20 article-title: UVC disinfects SARS-CoV-2 by induction of viral genome damage without apparent effects on viral morphology and proteins publication-title: Sci Rep doi: 10.1038/s41598-021-93231-7 – volume: 100 start-page: 476 year: 2020 end-page: 482 ident: B14 article-title: Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients publication-title: Int J Infect Dis doi: 10.1016/j.ijid.2020.09.025 – volume: 5 year: 2020 ident: B24 article-title: Effectiveness of face masks in preventing airborne transmission of SARS-CoV-2 publication-title: mSphere doi: 10.1128/mSphere.00637-20 – volume: 13 start-page: 233 year: 2019 end-page: 244 ident: B12 article-title: The emergence and prospects of deep-ultraviolet light-emitting diode technologies publication-title: Nat Photonics doi: 10.1038/s41566-019-0359-9 – volume: 8 start-page: 1014 year: 2020 ident: B3 article-title: Irradiation by a combination of different peak-wavelength ultraviolet-light emitting diodes enhances the inactivation of influenza A viruses publication-title: Microorganisms doi: 10.3390/microorganisms8071014 – volume: 106 start-page: 131104 year: 2015 ident: B16 article-title: Light extraction enhancement of 265 nm deep-ultraviolet light-emitting diodes with over 90 mW output power via an AlN hybrid nanostructure publication-title: Appl Phys Lett doi: 10.1063/1.4915255 – volume: 16 start-page: 439 year: 2009 end-page: 442 ident: B8 article-title: Ultraviolet light-emitting diodes in water disinfection publication-title: Environ Sci Pollut Res Int doi: 10.1007/s11356-009-0103-y – volume: 383 start-page: 592 year: 2020 end-page: 594 ident: B21 article-title: Transmission of SARS-CoV-2 in domestic cats publication-title: N Engl J Med doi: 10.1056/NEJMc2013400 – volume: 407 start-page: 281 year: 2010 end-page: 288 ident: B15 article-title: A simple and general method for determining the protein and nucleic acid content of viruses by UV absorbance publication-title: Virology doi: 10.1016/j.virol.2010.08.015 – volume: 9 year: 2014 ident: B23 article-title: Establishment and clinical applications of a portable system for capturing influenza viruses released through coughing publication-title: PLoS One doi: 10.1371/journal.pone.0103560 |
| SSID | ssj0001626676 |
| Score | 2.291737 |
| Snippet | We developed a 265-nm high-power DUV-LED irradiation system and quantitatively demonstrated that the DUV-LED can inactivate SARS-CoV-2 in suspensions and... Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (COVID-19) is an acute respiratory infection transmitted by droplets, aerosols, and... ABSTRACTSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (COVID-19) is an acute respiratory infection transmitted by droplets, aerosols,... ABSTRACT Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (COVID-19) is an acute respiratory infection transmitted by droplets, aerosols,... |
| SourceID | doaj pubmedcentral proquest asm2 pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | e0094121 |
| SubjectTerms | Aerosols Coronaviruses COVID-19 Decontamination deep UV Humans LED Light emitting diodes Mercury Research Article SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Suspensions Ultraviolet Rays Virology Viruses |
| SummonAdditionalLinks | – databaseName: American Society for Microbiology Open Access dbid: AAUOK link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1ba9swFBYlZbCXsfu8dUODMdiD2uToZj16vdDdR9uUvhnJlmggscOSDvrvd6Q47jJK2ZttSVg-R9L5js-NkHcoRLmVQ8dqrTwTI6uZrSu8zb3wATUKSCk2vn1Xx2Px-UJebBG5joXpKLjYtYtZMuT3Oxvyvdkihtr73egON2IxfHxbAl4OyHZRjH98ufm5gjBd6d4sectQPIHxDbAhjVLS_tuQ5r8Ok39JoKOH5EEHHWmx4vUjsuWbx-Teqpjk9RNSFhSUZHhctrPo40KjCwf7Gaug0QPv52x8Tr-mtCGHs0nydqYHk7b29MTOJ_X0mn5qYpDD7wg-6Wlxcsr223MGtPA49Xa6eErOjg7P9o9ZVz6BWWnEkhltQXGPUoojO2qHmqBA7QyccUoan0tkHwowXjmAYJ22tVHG1A48-Grk-DMyaNrGvyDUBhes9NFg74TLnbMiCCXqUOlqGEYqI-8jMcs188qkWUBedlQvE9VLGGVkb03usupykMdSGNM7RnzoR8xX-Tfu6PsxcrDvFzNnpwe4jspuI5ZCBe0VGMTBAaGkddaKmnPgIXeoHruM7Kz5f_M9yD5tELzlkJG3fTNuxGhdsY1vr1IfBUlFy8jz1XLpZ8Kl0FJzkRG9sZA2prrZ0kwuU7JvMxQC-fLyf0n8ityHGKExFAz0Dhksf13514iblu5Nt0v-AHbFFTk priority: 102 providerName: American Society for Microbiology – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9QwEA-yIPgifls9JYIIPsTdTr6ax_U-OEVF7ot7K0mbcAu77eLuHdx_f5O0V3dFzhcf2yQwmZlkZpLJbwh5j0aUWzlxrNbKM5FbzWxd4WfhhQ8YUUCC2Pj-Qx2eiq_n8nyj1FfMCevggTvGjYUK2isw6LcENP3WWStqzoGHwmE44-LuizZvI5hKpyvopys93EtCMV6s4jN9_ymm0uUsQoOO7GoBW-Yoofb_zdX8M2NywwQdPCIPe9-RTjuaH5N7vnlC7nfVJK-fknJKQUmG-2W7iEkuNOZwsJ-xDBrd837JTs_ot4Qbsr-YpXRnujdra0-P7HJWz6_plya-criK3ic9nh4ds932jAGdeiS9na-ekZOD_ZPdQ9bXT2BWGrFmRltQ3KOZ4iiP2mEoKDA8A2ecksYXEuWHFoxXDiBYp21tlDG1Aw--yh1_TkZN2_iXhNrggpU-3tg74QrnrAhCiTpUupqEXGXkQ2Rm2ev_qkyhBRRlz_Uycb2EPCPjW3aXVQ9CHmthzO8Y8XEYsewAOO7o-zlKcOgXobPTD1Sosleo8l8KlZGdW_n_ng-KTxv03grIyLuhGVdivF6xjW8vUx8FKUbLyItOXQZKuBRaai4yorcUaYvU7ZZmdpHQvs1ECJTLq_8xt9fkAcTnGxPBQO-Q0frXpX-DTtXavU3r5wairh5k priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dixMxEA9aEXwRv2_1lAgi-BDbTbLJ7pPU--AUFbkv-rYkm0QL7W697Qn33zuTbrdWpI-7SWAyk8nMJJPfEPIGjKgw2cgyp5VnMjWaGVfBZ-6lDxBR8Aix8fWbOrmQnyfZpDtwa7u0yvWeGDdq11R4Rj7kKtMF2M-cf1j8Ylg1Cm9XuxIat8kdhC7DVa0nenPGAt660v3tJM-H8xYf6_v3mFCXMgQIHZh2zreMUsTu_5_D-W_e5F-G6PgBud95kHS8EvlDcsvXj8jdVU3Jm8ekHFOYBINds5ljqgvFTA72HYuh0UPvF-zikn6J6CFH82lMeqaH08Z5emoWUze7oZ9qfOvwG31QejY-PWMHzSXjdOyB9GbWPiHnx0fnByesq6LATFbIJSu04Up4MFYCpOIsBIQSgjRuC6uywucZSBHsmKgs58FYbVyhisJZ7rmvUiuekkHd1H6PUBNsMJnHe3srbW6tkUEq6UKlq1FIVULeIjPLTgvaMgYYPC87rpeR6yVPEzJcs7usOihyrIgx2zHiXT9isYLh2NH3I0qw74cA2vFHc_Wj7PSxlCpor3gB7nAAj9JYY6QTgouQW4iSbUL21_LfzGezBhPyum8GfcRLFlP75jr2UTxGagl5tlouPSUikzrTQiZEby2kLVK3W-rpz4j5XYykBLk8303WC3KP4_OMkWRc75PB8uravwSnaWlfRc34Az7NFlA priority: 102 providerName: ProQuest |
| Title | A 265-Nanometer High-Power Deep-UV Light-Emitting Diode Rapidly Inactivates SARS-CoV-2 Aerosols |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/35475734 https://journals.asm.org/doi/10.1128/msphere.00941-21 https://www.proquest.com/docview/2657906482 https://www.proquest.com/docview/2656200255 https://pubmed.ncbi.nlm.nih.gov/PMC9044969 https://doaj.org/article/46f7e629507f423abaa4d3323f8b106b |
| Volume | 7 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bb9MwFLagE2gvE3cyRmUkhMSDt8Zx7PgBoWzrNC4bU7dOfYvsxIZKbVLaDtF_z7GTdhSVPUWJ7cjxZ-d8xz4XhN6CEI1U3NGkENwQFipBVJHDbWKYsaBRUB9i4-ycn_bZ50E8uHWPbgZwtlG1c_mk-tPR_u-fi4-w4D_UDjDJwXjmPPDNvrOSC4nzKt8CuSRcPoOzhuz7HRfg7lyszio3NNxGD6OYiVi4NMotNRvTNWnlg_pvYqL_GlT-JaFOHqGdhlritJ4Lj9E9Uz5BD-pkk4unKEsx5TGB32k1djYw2Jl4kAuXJQ0fGzMh_Wv81YcV6Y6H3hoaHw-rwuCemgyL0QJ_Kp0TxC9HTvFl2rskR9U1oTg10PVqNHuGrk66V0enpEmvQFQs2ZxIoSiPDEixCOAqNGiKDLQ3qqXmsTRJDPCCgItyTalVWqhCcikLTQ01eaij56hVVqV5ibCy2qrYuAN9zXSitWKWcVbYXOQdG_IAvXODmS3RzbzmQZOsASDzAGQ0DNDBcrizvIlR7lJljO5o8X7VYlLH57ij7qFDcFXPRdb2D6rp96xZqBnjVhhOJfBkC1RTaaVYEUU0sokG9VkHaG-J_-33AHxCArlLaIDerIphobrTF1Wa6sbX4dSrcAF6UU-XVU-Wsy5AYm0irXV1vaQc_vDBwGWHMcBl97_vfIW2qXPZ6DBCxR5qzac35jUQqbluo_tiINpoK037377A9bB7ftFr-22Jtl87fwAKbR81 |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdGEYIXxDeBAUYCJB5M24tjJw8IlXVTy7oJbd3UN8tOnK1Sm5S1A_WP4n_k7KYtRahve0ziRJfzff3s8x0h79CJhjpqGJZJYRlvasl0luJlbLnNEVGAL7FxdCw6Z_zbIBrskN_LszAurXJpE72hzsrUrZHXQUQyQf8Zw5fJD-a6Rrnd1WULjYVYHNr5L4Rs08_dNs7ve4CD_f5eh1VdBZiOEj5jidQgQovGO0QqM4MAiSNoAZMYESU2jvCv0K6HqQHItZE6S0SSZAYs2LRpQvzsLXIb_W7DYT05kOslHQQHQq42QyGuj6euNoD95PL3mszVI63p6Rg2fKBvFfC_-PbfNM2__N7BA3K_ClhpayFhD8mOLR6RO4sWlvPHRLUo8oyhkS7HLrOGusQR9t31XqNtayfs7Jz2fLGS_fHQ51jT9rDMLD3Rk2E2mtNu4Y5W_HQhLz1tnZyyvfKcAW1ZJL0cTZ-Q_k2w9ympFWVhnxOqc5PryLo0AcNNbIzmORc8y1OZNvKmCMgHx0xVKd1UeTwDsaq4rjzXFTQDUl-yW6VV5XPXgGO05Y2Pqzcmi6ofW8Z-dTO4Gufqdfsb5dWFqtRfcZFLKyDB6DvHAFYbrXkWhhDmsUFQbgKyu5z_9f-sRT4gb1ePUf3dno4ubHntxwjwwDAgzxbisqIkjLiMZMgDIjcEaYPUzSfF8NKXGE8anOO8vNhO1htyt9M_6qle9_jwJbkH7mRIgzOQu6Q2u7q2rzBem5nXXksoUTeslX8AGjdShQ |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NTiBeEN8EBhgJkHgwbR3HTh4Q6tZWKxtVtS_tzbITGyq1SVk7UP80_jvOadpShPq2xyR2dL7zne9nn-8A3uIiGuqoYWgmhaW8qSXVWYqPseXWIaJgZYqNr31xeM6_XEaXO_B7eRfGh1UubWJpqLMi9XvkdSYimeD6GbO6q8IiBu3u58kP6itI-ZPWZTmNxRQ5svNfCN-mn3ptlPU7xrqds4NDWlUYoDpK-IwmUjMRWjTkIVKcGQRLHAEMM4kRUWLjCEeINj5MDWNOG6mzRCRJZphlNm2aEH97C3alB0U12N3v9Acn6w0ehApCro5GWVwfT32mAPvRR_M1qc9OWtPTMdtYEcvCAf_zdv8N2vxrFezeh3uV-0pai_n2AHZs_hBuLwpazh-BahHkIEWTXYx9nA3xYSR04Cuxkba1E3p-QY7L1CWd8bCMuCbtYZFZcqInw2w0J73cX7T46R1gcto6OaUHxQVlpGWR9GI0fQxnN8HgJ1DLi9w-A6KdcTqyPmjAcBMbo7njgmculWnDNUUA7z0zVaWCU1WiGxariuuq5LpizQDqS3artMqD7stxjLb0-LDqMVnkANnSdt9LcNXOZ-8uXxRX31RlDBQXTlrBEvTFHbqz2mjNszBkoYsNQnQTwN5S_uvxrBUggDerz2gM_AmPzm1xXbYRrISJATxdTJcVJWHEZSRDHoDcmEgbpG5-yYffy4TjSYNzlMvz7WS9hjuokeq41z96AXeZvybS4JTJPajNrq7tS3TeZuZVpSYE1A0r5h-hYVgg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+265-Nanometer+High-Power+Deep-UV+Light-Emitting+Diode+Rapidly+Inactivates+SARS-CoV-2+Aerosols&rft.jtitle=mSphere&rft.au=Ueki%2C+Hiroshi&rft.au=Ito%2C+Mutsumi&rft.au=Furusawa%2C+Yuri&rft.au=Yamayoshi%2C+Seiya&rft.date=2022-04-27&rft.eissn=2379-5042&rft.volume=7&rft.issue=2&rft.spage=e0094121&rft_id=info:doi/10.1128%2Fmsphere.00941-21&rft_id=info%3Apmid%2F35475734&rft.externalDocID=35475734 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2379-5042&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2379-5042&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2379-5042&client=summon |